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ABSTRACT: Methacrylated poly(2-ethyl-2-oxazoline) (PEOZ) was synthesized by
partial hydrolysis of 500 kDa PEOZ, and the resulting poly[(2-ethyl-2-oxazoline)-co-
ethylenimine] P(EOZ-co-EI) was subsequently reacted with methacrylic anhydride. The
successful synthesis of methacrylated PEOZ (MAPEOZ) was confirmed by proton
nuclear magnetic resonance (1H NMR), infrared spectroscopy, and differential scanning
calorimetry. The degrees of hydrolysis and methacrylation were determined by 1H NMR
spectra. MAPEOZ exhibited temperature-responsive properties, which were dependent
on the degree of methacrylation. On that basis, three soluble MAPEOZ derivatives with
different degrees of methacrylation were selected and investigated in cell toxicity studies,
showing no significant cytotoxicity against the HEK293 cell line. A slug mucosal
irritation assay showed that PEOZ and MAPEOZ do not cause mucosal irritation. The
presence of methacryloyl groups and residual amines had a remarkable synergistic effect
on the mucoadhesive properties of these polymers. These poly(2-ethyl-2-oxazoline)
derivatives have excellent potential as mucoadhesive materials for developing formulations for drug delivery via mucosal routes of
administration.
KEYWORDS: poly(2-ethyl-2-oxazoline), mucoadhesion, mucoadhesive materials, methacrylated polymers, nasal drug delivery
1. INTRODUCTION
Nasal administration is a readily accessible route for non-
invasive treatment of rhinitis or nasal polyposis. Moreover, the
human nasal mucosa surface area is around 150 cm2, and, as a
tissue with a relatively high vascularization and permeability,
the nose is not only a therapeutic target but also a gateway for
systemic drug delivery.1,2 Consequently, dosage forms have
been developed for various therapeutic purposes, including
hormone replacement therapy,3 osteoporosis,4 migraine,5 and
prostate cancer,6,7 and have the potential to treat different
neurodegenerative disorders such as Alzheimer’s, Parkinson’s,
and Huntington’s diseases.8
However, the nasal cavity mucus layer can function as a
barrier to drug diffusion to the nasal epithelium, which can
result in poor drug bioavailability. To optimize nasal
administration, bioadhesive or, more appropriately, mucoadhe-
sive dosage forms such as microspheres,9−11 liposomes,12−14
and gels15,16 have been studied to prolong their residence in
the nasal cavity. Polymeric dosage forms exhibiting mucoad-
hesive properties are usually formulated using hydrophilic
polymers, which often demonstrate strong mucoadhesion.
Cationic polymers such as chitosan show strong mucoadhesive
properties due to interactions with mucosal surfaces.17−21 In
addition, some hydrophilic polymers with methacryloyl
groups,22 acryloyl groups,23−26 and maleimide27−29 can
covalently bond with the thiols present in mucus glycoproteins
through a Michael-type addition;30 catechol-functionalized
polymers formed covalent bonds with thiols in mucus
glycoproteins via catechol oxidation.31 Further, polymeric
thiomers, defined as polymers with −SH groups, formed
covalent disulfide bridges with thiols in mucus glycopro-
teins.32−34 Phenylboronic acid-decorated polymers can interact
with mucosal surfaces either through a covalent linkage with
the sialic acid present in mucins to form reversible covalent
complexes35−37 or via hydrogen bonds with the hydroxyl
groups present in oligosaccharide side chains.38
Poly(2-oxazolines) are an emerging class of polymers that
are attracting significant interest due to their unique
physicochemical properties and lack of toxicity.39−42 Poly(2-
methyl-2-oxazoline), poly(2-ethyl-2-oxazoline) (PEOZ), and
poly(n-propyl-2-oxazoline) are of particular interest as drug
delivery vehicles due to their solubility in water.43 However,
poly(2-oxazolines) themselves tend to be poorly mucoadhe-
sive. For example, we showed that thiolated silica nanoparticles
are mucoadhesive, but POZylated (functionalized with short-
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chain 5 kDa poly(2-oxazolines)) nanoparticles became non-
mucoadhesive in an ex vivo rat intestinal mucosal model44 and
enhanced mucus penetration through porcine stomach
mucosa.45 Larger molecular weight PEOZ (50, 200, and 500
kDa) exhibited weak mucoadhesive properties that were
improved by complexation or mixing with Carbopol,46 and
similarly, films formed from chitosan and PEOZ blends
demonstrated mucoadhesive properties with respect to bovine
cornea47 and sheep vaginal tissue.48 These studies indicate that
nonionic water-soluble poly(2-oxazolines) exhibit poor mu-
coadhesive properties unless mixed with more mucoadhesive
materials such as chitosan or Carbopol.
To enhance the mucoadhesion of poly(2-oxazolines), here
we have chemically modified the PEOZ backbone through
partial hydrolysis and a subsequent reaction of the resulting
poly[(2-ethyl-2-oxazoline)-co-ethylenimine] P(EOZ-co-EI)
with methacrylic anhydride, forming methacrylated (or
methacryloylated) polymers. The products were characterized
using spectroscopic (1H nuclear magnetic resonance (NMR),
Fourier transform infrared (FTIR), and UV−vis) and thermal
(differential scanning calorimetry (DSC)) methods. The
biocompatibility of the parent PEOZ and its hydrolyzed and
methacrylated derivatives was studied in the HEK293 cell line
and by using an in vivo slug mucosal irritation (SMI) assay.
Aqueous solutions of PEOZ and its methacrylated derivatives
containing sodium fluorescein were prepared and their
retention on sheep nasal mucosa was evaluated using a
fluorescence flow-through assay.
2. EXPERIMENTAL SECTION
2.1. Materials. Poly(2-ethyl-2-oxazoline) (PEOZ, 500 kDa,
dispersity Đ = 3−4), methacrylic anhydride, dimethyl sulfoxide
(DMSO), deuterated DMSO (DMSO-d6), deuterium oxide (D2O),
sodium fluorescein, glycol chitosan, benzalkonium chloride (BAC),
calcium chloride dihydrate (CaCl2·2H2O), sodium chloride (NaCl),
and potassium chloride (KCl) were obtained from Sigma-Aldrich
(Gillingham, U.K.). Hydrochloric acid (HCl; 37 wt %), triethylamine
(TEA; 99.7%, extra pure), and phosphate-buffered saline (PBS)
tablets were obtained from Fisher Scientific (Loughborough, U.K.).
Dialysis membrane with a molecular weight cutoff of 7 kDa was
purchased from Medicell Membranes Ltd. (U.K.). DMEM high
glucose was purchased from Capricorn Scientific (Germany). Fetal
calf serum (10%) was purchased from GE Healthcare Life Sciences.
Penicillin/streptomycin (1%) was purchased from Nacalai Tesque
Inc. (Japan). CellTiter 96 Aqueous MTS Reagent Powder was
purchased from Promega Corporation. Phenazine methosulfate was
purchased from Thermo Fisher Scientific.
2.2. Partial Hydrolysis of Poly(2-ethyl-2-oxazoline). PEOZ
was partially hydrolyzed to poly[(2-ethyl-2-oxazoline)-co-ethyleni-
mine], P(EOZ-co-EI), copolymers according to reported proce-
dures49,50 with minor changes. To study the hydrolysis kinetics,
PEOZ (20.0 g) was dissolved in 200 mL of 18 wt % aqueous HCl and
heated for 0.5, 1, 1.5, 2, 2.5, and 3 h at 100 °C. Subsequently, the
mixture was cooled in an ice−water bath to quench the reaction. The
obtained mixture was then mixed with a portion of deionized water
and purified by dialysis via a cellulose-based membrane with 7 kDa
MWCO at room temperature. All copolymers were recovered by
freeze-drying.
2.3. Synthesis of Methacrylated Poly(2-ethyl-2-oxazoline).
Methacrylated poly(2-ethyl-2-oxazoline) (MAPEOZ) was synthesized
by reacting ethylenimine groups of P(EOZ-co-EI) with methacrylic
anhydride to generate four derivatives (with four degrees of
methacrylation) according to the reported method22 with slight
modifications. Briefly, P(EOZ-co-EI) (1 equiv of amines) was
dissolved in a mixture of DMSO and deionized water (1:1 v/v).
Methacrylic anhydride (2.5 equiv) and TEA (2.5 equiv) were added
to the reaction mixture, which was stirred at 40 °C overnight. The
products were then redispersed in deionized water and purified by
dialysis at room temperature. All polymers were then recovered by
freeze-drying.
2.4. Characterization of Methacrylated Poly(2-ethyl-2-
oxazoline). 2.4.1. Proton Nuclear Magnetic Resonance (1H
NMR). 1H NMR spectra of polymers were recorded in D2O and
DMSO-d6 (15 mg/mL) using a 400 MHz Bruker spectrometer
(Nanobay). All chemical shifts are given in ppm. MestReNova
software was used for spectral analysis.
2.4.2. Fourier Transform Infrared (FTIR) Spectroscopy. FTIR
spectra were recorded using a diamond attenuated total reflection
(ATR) accessory on a Nicolet iS5 spectrometer. After a background
scan, data were collected between 4000 and 400 cm−1 at a resolution
of 4 cm−1 as an average of 64 scans; OMNIC software was used for
spectral analysis.
2.4.3. Differential Scanning Calorimetry (DSC). Samples (3−5
mg) were placed in pierced Tzero aluminum pans. The thermal
properties of each sample were investigated using a DSC (TA
Instruments) in a nitrogen atmosphere with a heating/cooling rate of
10 °C/min from 10 to 150 °C. The values of the glass-transition
temperature (Tg) were determined from the second heating cycle of
each sample.
2.4.4. 1H NMR to Calculate PEOZ Hydrolysis. Hydrolysis of
poly(2-ethyl-2-oxazoline) to poly[(2-ethyl-2-oxazoline)-co-ethyleni-
mine] was determined from 1H NMR spectra in D2O using the
signals (as shown in Figure S1) and the integrated areas (I) of the
peaks assigned to either PEOZ or its hydrolysis product; conversion
was calculated according to45
= [ ]








where I[EOZ] is the integral value of EOZ moieties and I[EI] is the
integral value of EI moieties.
2.4.5. 1H NMR to Determine the Composition of MAPEOZ
Samples. The degree of methacrylation was calculated from 1H NMR
spectra in D2O using the integrated areas (I) from the methacrylated
products (Figure S3).
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where I[MA] is the integral value of the backbone of methacrylated
moieties, I[EOZ] is the integral value of the backbone of EOZ groups,
and I[EI] is the integral value of EI groups.
Given that the signal of EOZ groups overlapped with the signal of
MA (Figure 2), according to
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where I[MA CH3] is the integral value of −CH3 of methacrylated
moieties and I[EOZ CH3] is the integral value of −CH3 of EOZ
moieties, eqs 2, 3, and 4 were modified to
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2.4.6. Turbidity Measurements. Turbidity measurements were
performed with a Cary 100 UV−vis spectrometer equipped with a
Cary temperature controller (Agilent Technologies). All polymers
were dissolved in deionized water (1 mg/mL) and measured at 600
nm with 1 °C/min ramp (measurement wait time of 30 s and
measurement interval of 1 °C). The absorbance data were converted
to transmittance by the following equation
= −T% 10 A (8)
where T is the transmittance and A is the absorbance. The resulting
value was then plotted as %T versus temperature.
2.5. In Vitro Nasal Mucoadhesion Studies. 2.5.1. Preparation
of Polymer/Fluorescein Sodium Mixtures and Artificial Nasal Fluid.
Artificial nasal fluid (ANF) was prepared using the established
protocols25,51 by dissolving 7.45 g of NaCl, 1.29 g of KCl, and 0.32 g
of CaCl2·2H2O in 1 L of deionized water. The artificial nasal fluid was
kept at 37 °C throughout the experiments.
Solutions of sodium fluorescein (0.05 mg/mL) were prepared in
deionized water into which polymer samples were dissolved; 10 mg of
either PEOZ, MA10PEOZ, MA25PEOZ, MA35PEOZ, or glycol
chitosan was dispersed in 10 mL of the sodium fluorescein solution
and the pH was adjusted to 5.70. These mixtures were stirred for 24 h
at room temperature until complete dissolution and were protected
from light with an aluminum foil.
2.5.2. Retention Studies on Nasal Mucosa. Sheep heads were
received from P.C. Turner Abattoir (Farnborough, U.K.) and used
within 24 h after animal slaughter. The nasal septum mucosal tissue
(1.5 × 1 cm2) was dissected with scissors and washed with 1 mL of
ANF.
All experiments assessing retention of formulations on nasal
mucosal tissues were conducted at 37 °C in an incubator. Images
of mucosal surfaces were taken using a fluorescence microscope
(MZ10F, Leica Microsystems, U.K.) equipped with an “ET GFP”
filter and a Zeiss Imager A1/AxioCam MRm camera. All images were
at 0.8× magnification with a 211 ms exposure time. Initially, the
fluorescence images of mucosal tissues were recorded for each sample
to collect the background fluorescence intensity. Then, 20 μL solution
of either 1 mg/mL PEOZ, MA10PEOZ, MA25PEOZ, MA35PEOZ, or
glycol chitosan containing 0.05 mg/mL sodium fluorescein was placed
on the mucosal surface and fluorescence images were recorded again.
After 3 min of dosing, the mucosal tissues were transferred to the
incubator and washed with ANF using a syringe pump at 0.43 mL/
min. Fluorescence images of the mucosal tissue were collected
periodically and analyzed using ImageJ software to measure the pixel
intensity after each wash. The results are presented as fluorescence
intensity as a function of the time of irrigation after subtracting the
background fluorescence from each wash image. Sodium fluorescein
solution in deionized water (0.05 mg/mL) was used as a negative
control, and glycol chitosan solution (1 mg/mL) was used as a
positive control. The experiments were conducted in triplicate.
2.6. Toxicology. 2.6.1. Cell Toxicity Studies. HEK293 was
cultured in DMEM high glucose supplemented with 10% fetal calf
serum and 1% penicillin/streptomycin. The cells were incubated at 37
°C in a humidified atmosphere of 5% CO2. Cell viability was assessed
using the CellTiter 96 AQueous Non-Radioactive Cell Proliferation
Assay (MTS assay). The cells were seeded in a 96-well plate at 3 ×
103 cells/well and incubated overnight for cell attachment. The cells
were then treated with various concentrations of the polymers (25, 50,
75, 100, 125, and 150 μg/mL) for 72 h. The negative control group
consisted of untreated cells and was considered as 100% of viable
cells. After 72 h, treatment media were replaced with new growth
media and 20 μL of MTS solution (prepared in phosphate-buffered
saline) containing 2 mg/mL CellTiter 96 Aqueous MTS Reagent
Powder and 0.92 mg/mL phenazine methosulfate. The cells were
incubated for another 4 h before the absorbance (Abs) was measured
at 490 nm using an Infinite 200 PRO microplate reader (Tecan
Group Ltd., Switzerland). The results are expressed as a percentage of










2.6.2. Slug Mucosal Irritation Assay. The slug mucosal irritation
(SMI) assay was performed according to our previous reports.52−54 A.
lusitanicus slugs were collected in Harris Garden (Reading, U.K.).
Slugs weighing between 6 and 18 g were individually placed in 2 L
glass beakers lined with a paper towel moistened with 20 mL of
phosphate-buffered saline (PBS; pH 7.40) and left for 48 h prior to
experiments. All beakers were covered with a pierced cling film. Each
slug was individually weighed and then placed in 90 mm plastic Petri
dishes lined with Whatman filter paper moistened with either 2 mL of
positive/negative controls (1% BAC prepared in PBS and PBS
solution) or 2 mL of each test material (PEOZ, MA10PEOZ,
MA25PEOZ, and MA35PEOZ) prepared in PBS. The concentration of
test materials (1 mg/mL) was chosen to correlate with nasal mucosal
retention studies. Slugs were kept in contact with the test samples for
60 min and then removed, rinsed with 10 mL of PBS, gently wiped,











where mb and ma are the weights of a slug before and after the
experiment, respectively. Each experiment was repeated five times
with different slugs, and the results were presented as mean ±
standard deviation.
2.7. Statistical Analysis. All experiments were conducted in
triplicate, and data were expressed as mean ± standard deviation with
a probability of p < 0.05 was considered as significant. GraphPad
Prism statistical analysis software (version 9.0) was used to analyze
data using a one-way analysis of variance (ANOVA) and paired t-
tests.
3. RESULTS AND DISCUSSION
3.1. P(EOZ-co-EI) Synthesis and 1H NMR Character-
ization. Complete hydrolysis of PEOZ to prepare pure linear
PEI was reported by our group recently55 and previously by
Hoogenboom et al.56,57 Here, we prepared partially hydrolyzed
PEOZ with some ethylene imine units remaining available for
further functionalization by reaction with methacrylic anhy-
dride (Figure 1).
To investigate the hydrolysis kinetics of PEOZ at 100 °C,
the reaction was terminated at different times (0.5, 1, 1.5, 2,
Figure 1. Synthesis of methacrylated poly(2-ethyl-2-oxazoline) (MAPEOZ).
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2.5, and 3 h). The 1H NMR spectra of these copolymers
showed signals corresponding to the PEOZ backbone at 3.5
ppm (peak a, Figure S1) with signals 2.44 ppm (peak c) and
1.13 ppm (peak d) attributed to PEOZ side chains. Partial
hydrolysis of PEOZ was confirmed not only by both reduced
signals from PEOZ side chains and reduced and broadened
signals from the PEOZ backbone but also by a reaction time-
dependent increasing signal at 3.34 ppm (peak b, Figure S1),
which was attributed to the backbone of PEI moieties. The
degree of conversion from PEOZ to P(EOZ-co-EI) was
calculated using eq 1 and was plotted versus time (Figure
S2). Under our reaction conditions, hydrolysis of PEOZ
follows first-order kinetics, which is slightly different from a
previous report49 where pseudo-first-order kinetics was
reported when using a microwave synthesizer with closed
reactors and a lower HCl concentration. Taken from Figure S2,
conversion from PEOZ to P(EOZ-co-EI) at 0.5, 1, 2, and 3 h
was 15, 28, 53, and 78% of EI, respectively (Table S1).
3.2. Synthesis and Characterization of Methacrylated
PEOZ. The secondary amines present in P(EOZ-co-EI) offer
reactive sites for further methacrylation by reaction with
methacrylic anhydride in the presence of TEA as a basic
catalyst. P(EOZ-co-EI) copolymers prepared following 0.5, 1,
2, and 3 h of partial hydrolysis were selected for further
methacrylation. The resultant MAPEOZ polymers were
characterized using 1H NMR, FTIR, and DSC.
The 1H NMR spectra of MAPEOZ polymers showed signals
corresponding to the backbone of EOZ repeating units as well
as the backbone of methacrylated units at 3.5 ppm (peak a,
Figure 2); the signals labeled as c (2.44 ppm) and d (1.13
ppm) are attributed to the methylene and methyl groups of
EOZ units, respectively. The signal characteristic for the
backbone of unreacted EI units shifted from 3.10 ppm (peak b,
Figure S1) to 2.71 ppm (peak b, Figure 2) upon modification.
The signals labeled e (5.0−5.5 ppm) and f (1.86 ppm) are
attributed to the protons of the double bond and methyl of the
methacryloyl group, respectively. Increasing methacrylation or
decreasing EOZ units, in other words, led to a significant
weakening of peaks c and d and strengthening of peaks e and f.
It should be noted that the 1H NMR spectrum of MA55PEOZ
was recorded both in DMSO-d6 and in D2O since this sample
exhibited limited solubility in D2O (discussed below). The
chemical shifts of protons of MA55PEOZ in DMSO-d6 were
consistent with the spectra of other samples recorded in D2O,
with some expected minor shifts related to the switch of
solvent (Figure S3).
The compositions of MAPEOZ polymers were calculated
using eqs 5−7 and are presented in Table 1. As expected,
methacrylation increased with PEOZ hydrolysis, and for
clarity, the methacrylated polymers are annotated with their
MA content (i.e., MA10PEOZ contains 10% MA groups and
was synthesized from the PEOZ sample that had hydrolyzed
for 0.5 h). It can be seen that the secondary amines were not
completely substituted by methacryloyl groups due to steric
hindrance with 1, 5, 13, and 18% residual EI units remaining in
the four MAPEOZ products. The proportion of EOZ units
(89, 70, 52, and 27%, Table 1) in the four MAPEOZ samples
Figure 2. 1H NMR spectra of MAPEOZ recorded in D2O.









P(EOZ-co-EI15) MA10PEOZ 89 1 10
P(EOZ-co-EI28) MA25PEOZ 70 5 25
P(EOZ-co-EI53) MA35PEOZ 52 13 35
P(EOZ-co-EI78) MA55PEOZ (D2O) 27 18 55
MA55PEOZ (DMSO-d6) 26 19 55
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shows good agreement with the PEOZ to P(EOZ-co-EI)
hydrolysis study (85, 72, 47, and 22%, Table S1). The
composition of MA55PEOZ calculated from
1H NMR spectra
recorded in D2O (27% EOZ, 18% EI, and 55% MA) was in
good agreement with the composition determined in DMSO-
d6 (26% EOZ, 19% EI, and 55% MA).
Infrared analysis of PEOZ provided peaks at 2977 and 2940
cm−1 (CH2 stretch) (Figure S4), 1626 cm
−1 (CO stretch),
1470 cm−1 (C−H bending), 1420 cm−1 (C−H bending), and
1240 cm−1 (C−N stretch). New peaks at 1719 and 916 cm−1
(Figure 3), assigned to the stretching mode and bending
modes of C−H, became evident with increasing meth-
acrylation, which further confirmed its successful modification.
In addition, it is notable that the peak attributed to the
carbonyl group of MAPEOZ gradually shifted to lower
wavenumbers (1622 cm−1 for MA10PEOZ, 1617 cm
−1 for
MA25PEOZ, 1614 cm
−1 for MA35PEOZ, and 1611 cm
−1 for
MA55PEOZ) with increasing methacrylation. It is problematic
to detect EI moieties in these FTIR spectra because the
characteristic N−H bending mode of EI at 1474 cm−1 5555
overlaps with the C−H bending mode of EOZ moieties at
1470 cm−1.
PEOZ and MAPEOZ samples were also analyzed using
differential scanning calorimetry (Figure 4). PEOZ,
MA10PEOZ, MA25PEOZ, MA35PEOZ, and MA55PEOZ
showed glass-transition temperatures (Tg) at 60.7, 62.5, 64.4,
65.2, and 68.7 °C, respectively. The increase in Tg with an
increasing degree of methacrylation in MAPEOZ can be
explained by the lower flexibility of the macromolecules with
bulky groups, which decreases the overall chain mobility.
The thermal properties of the new polymers were also
studied in aqueous solutions. To this end, PEOZ and
MAPEOZ samples (1 mg/mL) were dissolved in deionized
water, and their phase behavior was studied by measuring
solution turbidity between 5 and 95 °C (Figure 5a). The
literature describes various methods to determine the cloud
point (Tcp), including the onset of the fall in transmittance, or
the temperature where transmittance is 80 or 50%, or by taking
the inflection point of the turbidity curve.58 Here, the onset of
the fall in transmittance was used as this value was accessible
for all MAPEOZ samples. PEOZ exhibited a cloud point of 67
°C, in agreement with the literature where PEOZ undergoes
Figure 3. FTIR spectra of PEOZ and MAPEOZ in the range of
2100−600 cm−1.
Figure 4. DSC thermograms (second scan) of PEOZ and MAPEOZ
samples showing increasing glass-transition temperatures with
increasing methacrylation.
Figure 5. (a) Turbidity measurements of aqueous solutions of PEOZ
and MAPEOZ samples (1 mg/mL). (b) Tcp as a function of MA mol
% in MAPEOZ polymers.
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phase separation between 61 and 70 °C, depending on the
molecular weight and the solution concentration.59,60
Methacrylate groups of MAPEOZ make the macromolecules
more hydrophobic.61 Therefore, increasing the proportion of
MA was expected to lower Tcp. However, the results showed
the opposite trend with Tcp increasing with increasing
methacrylation; Tcp values for MA10PEOZ, MA25PEOZ, and
MA35PEOZ were 70, 74, and 79 °C, respectively (Figure 5).
The unexpected increase in Tcp may be explained by the
increasing proportion of hydrophilic EI units that accompanies
the increase in methacrylation (Table 1), and indeed, these
may be positively charged upon protonation62 such that the
Figure 6. (a) Fluorescence images showing retention of 1 mg/mL glycol chitosan, PEOZ, MA10PEOZ, MA25PEOZ, and MA35PEOZ solutions
using 0.05 mg/mL sodium fluorescein as the solvent and pure 0.05 mg/mL sodium fluorescein solution on sheep nasal mucosa and washed with
ANF. Scale bars are 2 mm. (b) Retention of 1 mg/mL glycol chitosan, PEOZ, MA10PEOZ, MA25PEOZ, and MA35PEOZ solutions using 0.05 mg/
mL sodium fluorescein as the solvent and pure 0.05 mg/mL sodium fluorescein solution on sheep nasal mucosa as washed with different volumes
of ANF (pH = 5.70; n = 3, mean ± SD, “*” represents p < 0.05; “**” represents p < 0.01; “***” represents p < 0.001).
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hydrophilicity of the whole macromolecule was improved.
Interestingly, increasing the MA from 35 to 55% decreased the
Tcp to a temperature below 5 °C (Figure 5b); the aqueous
solution of MA55PEOZ was already cloudy at 5 °C. It is
feasible that the high hydrophobic MA content in MA55PEOZ
(MA% 55%) dominates the hydrophilic contribution of the EI
groups and makes the macromolecules more hydrophobic than
the parent PEOZ. The variability of Tcp with both MA and EI
content suggests that systems can be tuned to provide a cloud
point for desired applications.
3.3. In Vitro Nasal Mucoadhesion Studies. Given the
limited water solubility of MA55PEOZ at 37 °C, this polymer
was not used in subsequent studies.
The retention of PEOZ, MA10PEOZ, MA25PEOZ, and
MA35PEOZ solutions with sodium fluorescein was evaluated
on sheep nasal mucosa and washed with ANF. Glycol chitosan
was used as a positive control with strong mucoadhesive
properties,19 whereas sodium fluorescein was used as a
negative control. Figure 6 shows the retention of sodium
fluorescein mediated with glycol chitosan, PEOZ, MA10PEOZ,
MA25PEOZ, and MA35PEOZ on sheep nasal mucosa.
Numerical values from these experiments are summarized in
Table S2.
As expected, the water-soluble dye sodium fluorescein was
poorly retained when dosed from a simple aqueous solution
and was rapidly washed from the nasal mucosa surface with
only ∼5.7% of the initial fluorescence detected after 60 min of
washing (Figure 6b). This residual fluorescence results from
the penetration of sodium fluorescein into the biological tissue
rather than its adhesion to the surface. Retention of sodium
fluorescein was not improved in the presence of unmodified
PEOZ, confirming the poor mucoadhesive properties of PEOZ
shown in our previous studies44 and attributed to the nonionic
nature of this polymer.30 PEOZ samples chemically modified
through hydrolysis and subsequent methacrylation significantly
improved sodium fluorescein retention on the mucosal surface.
Particularly notable at shorter irrigation times (5, 10 min),
increasing methacrylation led to a greater retention of the
fluorescent dye. For example, after 5 min of washing, ∼50% of
the dye was retained when administered with MA35PEOZ
compared with 42% retention when using MA25PEOZ and
35% of the dye was retained when deposited with MA10PEOZ.
Indeed, after 5 min of irrigation, MA35PEOZ retained
significantly more sodium fluorescein than the positive control
(cationic glycol chitosan) (p < 0.05).
As expected, retention declines with irrigation time, but the
trend remains that mucoadhesion/mucoretention of the
polymers is in the order MA35PEOZ > glycol chitosan >
MA25PEOZ > MA10PEOZ > PEOZ. It can be hypothesized
that MAPEOZ polymers interact with mucosal surfaces
through two mechanisms as shown in Figure 7: (1) the
methacrylate groups could potentially form covalent bonds
with the thiol groups present in mucins at the mucosal surface;
(2) electrostatic interaction between cationic secondary
amines within the polymer and negatively charged mucins
due to the presence of carboxylate groups and ester sulfates in
their structure.32 It is likely that the strong mucoadhesive
properties of the MAPEOZ result from the synergistic positive
effects from both the MA groups and residual secondary
amines being available to interact with the mucosal surface.
3.4. Cell Toxicity Studies. The HEK293 cell line,
consisting of immortalized human embryonic kidney cells,
has been used for in vitro toxicity testing with varied
toxicological endpoints.63 The effects of the polymers on
HEK293 cell viability were studied over 72 h using the MTS
assay (Figure 8); numerical values as mean ± standard
deviation are summarized in Table S3. Poly(2-oxazolines) have
demonstrated excellent biocompatibility in a number of studies
and are proposed as a versatile platform for biomedical
applications,39,64 but here, PEOZ was found to moderately
affect HEK293 cells, notably at >100 μg/mL where cell
viability fell to below 90%, consistent with a previous study.65
Hydrolyzed PEOZ with 15 mol % EI units (P(EOZ-co-EI15))
showed a similar cell viability trend to PEOZ, suggesting that
Figure 7. Proposed mechanism of interaction between MAPEOZ polymers and mucosal surfaces.
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15% EI did not alter the biocompatibility of the copolymer.
However, poly(ethylenimine) (PEI), a widely used transfection
agent, is known to be toxic, and so it is unsurprising that as the
EI content in our hydrolyzed PEOZ increases, the cell viability
declines. For example, when applied at 100 μg/mL, P(EOZ-co-
EI15) with 15 mol % EI units retained >87% cell viability, but
this fell to 57% when treated with the polymer containing 28
mol % EI units and less than 3% of cells remained viable when
treated with the polymer containing 53 mol % EI units at the
same concentration. It is known that the positive charges of EI
can induce cell death and apoptosis and cause toxicity both in
vitro and in vivo.66
Although the MAPEOZ polymers formed from the P(EOZ-
co-EI) retain some EI units (Table 1), methacrylation
essentially reverses or “blocks” the toxicity of the intermediate
polymer and cell viability returns to the same levels seen with
the parent PEOZ with >90% cell viability for PEOZ and all
MAPEOZ samples when dosed at 25 μg/mL and 88−90%
viability for all when dosed at 100 μg/mL. The introduction of
MA groups clearly reduced the cellular toxicity of hydrolyzed
PEOZ, suggesting the equivalent biocompatibility of our
modified MAPEOZ with the parent poly(2-ethyl-2-oxazoline).
3.5. Mucosal Irritancy. The slug mucosal irritation (SMI)
in vivo assay, developed by Adriaens and co-workers,67,68 was
used to evaluate the toxicological properties of PEOZ and its
methacrylated derivatives. This test has been validated as a
reliable method and is useful as a prescreen assay for evaluating
the irritation potential of chemicals, formulations, and active
ingredients to different mucosal membranes, including
evaluation of nasal irritation.69−73 The slug’s mucosal layer is
located at the outer surface of the body and, for this reason, it
is easily observable by the investigator. In this test, colorless
mucus, secreted by slugs after contact with a test substance, is a
good initial indicator of biocompatibility. The total amount of
mucus production serves as the main criterion to test the
biocompatibility of formulations since this increases on
exposure to stronger irritants.54,67,74 These assessments
provide quantifiable data for test materials to be classified as
nonirritating, mild, moderate, or severely irritating.72,73
Figure 9 shows the data on mucus production by slugs
exposed to filter paper surfaces soaked in PEOZ and its
modified derivatives solutions at 1 mg/mL prepared in PBS, as
well as positive and negative controls. On exposure to 1% BAC
in PBS (positive control; pH 7.37), slugs experienced severe
irritation (p < 0.0001), producing ∼43 ± 8% of yellow mucus,
compared to slugs exposed to PBS (negative control; pH 7.40)
with a very low level of mucus production (2 ± 1%). These
data are in good agreement with our previous reports.53,54
Mucus production recorded for the slugs exposed to the
solutions of PEOZ, MA10PEOZ, MA25PEOZ, and MA35PEOZ
(pH 7.47) was 2 ± 1, 3 ± 1, 3 ± 1, and 2 ± 1% of colorless
mucus, respectively. No significant differences (p ≫ 0.05) in
mucus production were seen between values recorded for the
negative control and test materials, indicating the nonirritating
nature of both PEOZ and modified PEOZs (Figure S5
provides the images with A. lusitanicus slugs exposed to various
test materials).
4. CONCLUSIONS
This study demonstrated successful methacrylation of poly(2-
ethyl-2-oxazoline) through a reaction between hydrolyzed
poly(2-ethyl-2-oxazoline) bearing secondary amino groups and
methacrylic anhydride. The structure and physicochemical
behavior of these polymers were studied using 1H NMR,
FTIR, and UV/vis spectroscopies and differential scanning
calorimetry. Methacrylated PEOZ showed temperature-de-
pendent phase separation in aqueous solutions, and the cloud
point temperature values were dependent on the degree of
polymer modification. Cell toxicity studies demonstrated
equivalent biocompatibility of the methacrylated polymers
with the parent poly(2-ethyl-2-oxazoline), although the
intermediate hydrolyzed product was toxic. Slug mucosal
irritation tests demonstrated the nonirritant nature of
methacrylated PEOZ. Methacrylation significantly increased
mucoadhesion on the nasal mucosa tissue compared to parent
poly(2-ethyl-2-oxazoline) attributed to the synergistic binding
of methacrylate groups as well as residual secondary amines
being available to interact with the mucosal surface.
Methacrylated PEOZ can potentially be used as a mucoadhe-
sive material in dosage forms for transmucosal drug delivery.
Figure 8. Viability of HEK293 cells determined after treatment with
PEOZ, P(EOZ-co-EI15), P(EOZ-co-EI28), P(EOZ-co-EI53),
MA10PEOZ, MA25PEOZ, and MA35PEOZ for 72 h. The untreated
cells served as the control. Values are expressed as means ± SD (n =
3).
Figure 9. Mucus production by Arion lusitanicus slugs in response to
60 min exposure to PEOZ and its methacrylated derivatives as well as
positive (BAC) and negative (PBS) controls. Statistically significant
differences are given as follows: ****p < 0.0001; ns: no significance.
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To the best of our knowledge, this is the first study reporting
the chemical modification of the PEOZ backbone to enhance




The Supporting Information is available free of charge at
https://pubs.acs.org/doi/10.1021/acsapm.1c01097.
(Figure S1) 1H NMR spectra of PEOZ and hydrolyzed
PEOZ in D2O; (Figure S2) first-order kinetic plot for
the hydrolysis of PEOZ 500 kDa at 100 °C, [HCl] = 18
wt %; (Table S1) composition of P(EOZ-co-EI)
calculated from the standard curve in Figure S2; (Figure
S3) 1H NMR spectrum of MA55PEOZ in DMSO-d6;
(Figure S4) FTIR full spectra of PEOZ and MAPEOZ;
(Table S2) retention values of 1 mg/mL glycol chitosan,
PEOZ, MA10PEOZ, MA25PEOZ, and MA35PEOZ
solutions using 0.05 mg/mL sodium fluorescein as the
solvent and pure 0.05 mg/mL sodium fluorescein
solution on sheep nasal mucosa as washed with different
volumes of ANF (pH = 5.70); (Table S3) values of
viability of HEK293 cells determined after treatment
with different concentrations (25, 50, 75, 100, 125, and
150 μg/mL) of PEOZ, P(EOZ-co-EI15), P(EOZ-co-
EI28), P(EOZ-co-EI53), MA10PEOZ, MA25PEOZ, and
MA35PEOZ for 72 h; and (Figure S5) photographs of
mucus production by Arion lusitanicus slugs in contact
with positive (1% solution of BAC in PBS) and negative
(PBS solution) controls as well as PEOZ and its
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